461 articles in this topic
Semaglutide and liraglutide show promise for dry eye and corneal repair, but may cause periocular volume loss that affects blinking and tear distribution.
Aging adipose tissue loses its ability to generate new fat cells, driving insulin resistance. New review maps the molecular culprits and best treatment options.
A new framework reveals how lactate and β-hydroxybutyrate team up across organs to regulate metabolism, mitochondria, and disease.
A systematic review of 13 studies finds semaglutide and liraglutide meaningfully cut BMI and improve blood sugar in children and adolescents.
Peter Attia breaks down the real impact of Ozempic and Wegovy on muscle, bone, and physical function — and how to protect both.
New research shows chronic semaglutide treatment causes weight loss while leaving taste perception fully intact, pointing to motivational rather than sensory mechanisms.
A new review argues that combining GLP-1 receptor agonists with structured exercise and dietary support preserves muscle and delivers lasting fat loss.
A Phase 1 trial tests whether lowering compensatory hyperinsulinemia with diazoxide improves glucose and lipid metabolism in NAFLD patients.
A real-world study of 549 patients finds that combining GLP-1 receptor agonists with SGLT-2 inhibitors meaningfully improves glucose control — and baseline HbA1c predicts who benefits most.
Dr. Berg explains how frequent eating keeps insulin chronically elevated, driving insulin resistance, belly fat, and metabolic disease.
Dr. Berg fields real-time questions on H. pylori, ferritin, kidney stones, keto troubleshooting, and stem cell therapy in a wide-ranging live show.
A day-by-day breakdown of prolonged fasting effects — from insulin drops to autophagy, HGH surges, and cellular repair.
